MAIRE's Nextchem awarded NX CONSER C5+ license and process design for TMA plant in China

Key highlights
  • Nextchem/Conser awarded license, process design package and technical services by a Chinese firm for a new Trimellitic Anhydride (TMA) plant in China.
  • Project uses Nextchem's NX CONSER C5+ continuous TMA technology, reducing power, steam and water consumption.
  • Execution is split into two phases with an option to supply proprietary equipment at a later stage.
  • TMA will be used as an intermediate for high-performance PVC plasticizers, coatings and polyester resins for electrical, automotive and medical applications.

Contract and scope

Nextchem, through its Conser subsidiary, was awarded the licensing, Process Design Package and technical services by a Chinese client for a new Trimellitic Anhydride (TMA) plant in China.

Technology

The plant will deploy Nextchem’s proprietary Trimellitic Anhydride technology from the NX CONSER C5+ portfolio for continuous TMA production, aiming to reduce power, steam and water consumption while meeting safety and reliability requirements through selected construction materials.

Project delivery

The project is structured in two execution phases to enable progressive implementation aligned with the client’s strategy; the contract includes an option to supply proprietary equipment at a later stage.

Applications

TMA will serve as an intermediate for high-performance PVC plasticizers used in electrical, automotive and medical applications, and for coating formulations and polyester resins.

Source: NextChem

chemXplore Weekly

The week’s project milestones and project news from the chemical industry, free every Wednesday.

Free. One email a week. Unsubscribe any time.

Related articles

28 April 2026
MAIRE’s Nextchem wins TMA licensing, process design and technical services contract in China with NX CONSER C5+

Continuous TMA production tech delivers power, steam and water savings. TMA feeds PVC plasticizers, coatings and polyester resins. Project in two phases with optional proprietary equipment supply.

30 July 2026
MAIRE: H1 2026 results — €3.7bn revenues, strong order intake and M&A in Nextchem

Revenues +6.9% to €3.68bn; EBITDA +14.7% to €266.2m; H1 order intake €7.2bn, backlog €16.3bn; Nextchem buys Ballestra and 70% of ETEK.

29 April 2026
MAIRE Q1 2026: Revenues & EBITDA up; 2026 guidance confirmed

Q1: Net income €76.7m (+19.9%); adjusted net cash €396.1m; order intake €4.78bn; backlog €15.73bn; Nextchem revenue +46%; record dividend €0.585/share